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Abstract
Wait time and scheduling for outpatient chemotherapy administration depends on various factors including infusion room hours of
operation, availability of oncologists, nursing and pharmacy staffing, and physical space limitations. The aim of this study was to use
the electronic event log of patients on health information system (HIS) to map and analyze patient flow in advanced metastatic
colorectal patients at an academic cancer center. From January 2009 to December 2014, patients who were diagnosed with
metastatic colorectal cancer and received outpatient chemotherapy confined to FOLFIRI (fluorouracil, leucovorin, and irinotecan) or
FOLFOX (folinic acid, fluorouracil, and oxaliplatin) were identified. From the HIS, patient flow was mapped by collection of event
records including blood collection and pretreatment laboratory test, arrival to outpatient clinics, outpatient session (interview, drug
accountability and appointment scheduling), and initiation of chemotherapy. A total of 10,638 patients were analyzed for 136,281
outpatient visits. The total office stay time from outpatient registration to initiation of chemotherapy was 92.58±87.96 (mean±
standard deviation) minutes. Each outpatient session lasted 23.75±51.55minutes. After completing the outpatient session, patients
waited 1,657.23±3,027.65 minutes before chemotherapy and 46.66±75.94 minutes within infusion room. Compared to the prior
first come first serve rule, the new reservation system showed an improvement in overall waiting time from 2,432.3±4,822.9 to
2,386.7±143.4 minutes; however, waiting time within infusion room slightly increased from 36.68±49.33 to 48.13±46.32 minutes.
Our findings indicate that transaction data analytics from HIS can be used to evaluate patient flowwithin oncology outpatient practice
based on real-world hospital data.
Abbreviations: FOLFIRI= fluorouracil, leucovorin, and irinotecan, FOLFOX= folinic acid, fluorouracil, and oxaliplatin, HIS=Health
Information System.
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The care of cancer patients involves multiple departments within
the hospital at various levels.[1] Due to the complexity, the flow
between office visits to infusion units is essential for adequate
delivery of care throughout the system. Delays within this flow
are major sources of overall dissatisfaction among patients and
health care providers.[2,3]
Asan Medical Center (AMC) is the largest medical institute in
Korea and attends to 10,000 outpatients per day. The
chemotherapy day unit is a 119-chair unit, dedicated to delivering
systemic anticancer treatments to day-admitted patients, cur-
rently provides upward of 1000 treatment episodes per month.
Everyday patients experience multiple checkpoints before
receiving chemotherapy. Therefore, the importance of incorpo-
rating both clinical and administrative data across departments is
essential to increase efficiency in the delivery of health care
services.
AMC has developed integrated healthcare information system
(HIS) through the Asan Medical Information System built in-
house by our medical information-development team.[4] Asan
Medical Information System includes order communication
system including computerized physician order entry system,
picture archiving communication system (PACS), electronic
medical record system, laboratory electronic blood-tracking
information system, pharmacy and Asan BiomedicaL research
Environment, the Asan clinical research data warehouse. AMC
Kim et al. Medicine (2020) 99:39 Medicinehas also developed an Integrated Patient Monitoring System.
Four monitoring systems are operative; these allow integration of
inpatient bedmanagement, an outpatient wait scheduling system,
an operation theater management process system, and an
integrated laboratory reservation monitoring system. However,
despite these efforts, office waiting time is still an issue.
It is difficult to objectively measure time delays in real-world
practice because of the variation in clinical scenario of each
visit between and within each patient. In this retrospective
analysis, we propose using hospital transaction data to measure
patient time and map patient flowwithin the office and infusion
room. Specifically, we describe the architectural framework
and descriptive analytics from a high-volume cancer center.
We also assess the real-world impact of quality improvement
efforts within scheduling infusions on office waiting times. To
decrease the variation associatedwith different cancer types, we
confined our evaluation to metastatic colorectal cancer patients
who were receiving either first or second-line FOLFOX or
FOLFIRI chemotherapy. As targeted agents including bevaci-
zumab and antiepidermal growth factor receptor (EGFR)
therapy were not reimbursed until 2014, regimens containing
these agents were not included. To our knowledge, this is the
first study that uses a combination of health administrative and
clinical data to map patient and workflow based on real-time
hospital data.2. Materials and Methods
2.1. Patients and operational flow
The data were extracted from deidentified clinical data
warehouse.[5] Patients who were diagnosed with metastatic
colorectal cancer and received first or second-line chemotherapy
consisting of FOLFOX (oxaliplatin 85mg/m2 intravenously over
2 hours+ leucovorin 400mg/m2 intravenously over 2hours,
followed by 5-FU 400mg/m2 intravenous bolus, followed by
5-FU 2,400mg/m2/d intravenously as a 46-hour continuous
infusion every 2 weeks) or FOLIRI (irinotecan 150 or 180mg/m2
intravenously over 90 minutes+ leucovorin 400mg/m2 intrave-
nously over 2hours, followed by 5-FU 400mg/m2 intravenous
bolus, followed by 5-FU 2,400mg/m2/d intravenouly as a 46-
hour continuous infusion every 2 weeks) at the outpatient office
between January 2009 to December 2014 were extracted to the
total number of patients was 11,220, and these patients visited
193,401 times. As targeted agents including bevacizumab and
anti-EGFR therapy were not reimbursed only a selected number
of patients received regimen including these agents and were
excluded from this analysis. Therefore, 10,368 patients who
visited 136,281 times were included in this study.
Current operational and clinical processes were identified, and
the workflowwas examined (Supplement Fig. 1 http://links.lww.
com/MD/E926). Patients undergo blood collection 2 hours prior
to the appointment time, after which they would register at the
outpatient office, and vital parameters are taken at the triage/
waiting area. Patients enter the office room and begin outpatient
sessions (medical interview, drug accountability, and appoint-
ment scheduling). Chemotherapy orders are then submitted to
the pharmacy real-time via computerized physician order entry
system, and patients proceed to the chemotherapy day unit and
wait for drug preparation and initiation of parenteral chemo-
therapy (FOLFOX or FOLFIRI). After bolus 5-FU and
oxaliplatin or irinotecan administration, the patient receives2
infusional 5-FU via an implantable central venous port system
and ends the visit. All activities occur within a single building.
Each treatment visit was mapped into the following steps that
had digital log time points within the data warehouse: blood
collection and reporting for pretreatment laboratory test, arrival
to outpatient registration, outpatient session (medical interview,
drug accountability and appointment scheduling), and initiation
of chemotherapy (Supplement Fig. 1 http://links.lww.com/MD/
E926). The following definitions were used: total office stay time
as the time between registration and end of session; office waiting
time as the time between registration and start of session; infusion
room waiting time as the time between end of session and
initiation of chemotherapy infusion.2.2. Data collection
The collected data were reconstructed based on event-driven
patient-tracking approach. Event-driven patient-tracking ap-
proach is to track patients by deducing their location through
changes in their last known status. Most data from HIS can be
used as source data to reproduce patient flow, for instance, when
the patient receive computed tomography scanning the time log is
made within picture archiving communication system without
any manual efforts. When a patient has moved from outpatient
waiting room to doctor’s office, this data is recorded at
management of electronic display board which is a submodule
of our HIS.
Two data sets were collected in this study for event-driven
patient tracking. First, data from January 2009 to December
2014, this data was collected to determine the overall waiting
time for outpatient chemotherapy patients. Secondly, data from
January 2013 to December 2017 were collected to analyze the
effects of changing the reservation systems in infusion room. In
May 2014, the infusion room appointments were changed from a
first come, first served basis to a reservation system. To evaluate
the effects of the reservation system, data from January 2013 to
February 2014 and from May 2014 to December 2017 were
grouped separately and termed as pre and postinitiative,
respectively. Two months between the pre and postinitiative
periods were excluded from the test period after the introduction
of the reservation system.2.3. Statistical analysis
All data were based on descriptive analysis. Time points for blood
collection and reporting for pretreatment laboratory test, arrival
to outpatient registration, outpatient session (medical interview,
drug accountability, and appointment scheduling), and initiation
of chemotherapy were obtained. Intervals between time points
were analyzed. Time dependency was evaluated with hours
within a day, days within a week, and months within a year. The
comparative evaluation of pre and postinitiatives in the infusion
room was conducted using a t test for the following 2 aspects: the
difference in waiting time before the patient arrived at the
infusion room, and the waiting time within the infusion room.
Segmented regression is an analytical method that examines
the difference between before and after trends and gaps when
there is an intervention during the study period, and especially
examines the effect of intervention.[6] In this paper, we use the
SAS 9.4 version of the PROC AUTOREG procedure to take into
account the autocorrelation of the mean waiting time in infusion
room.[7] The number of patients at each time point was used as a
Kim et al. Medicine (2020) 99:39 www.md-journal.comcalibration variable. All reported P values were 2-sided, and
P< .05 was considered significant. SAS version 9.4 and R
software (ver. 3.3, http://cran.r-project.org/) was used for the
statistical analyses.
2.4. Ethical statement
This study was approved by the institutional review board of the
hospital (IRB no. 2015-1379). The need for informed consent
was waived by the ethics committee, as this study utilized
routinely collected log data that were anonymously managed at
all stages, including data cleaning and statistical analyses.3. Results
Between January 2009 to December 2014, a total of 10,638
patients were analyzed for 136,281 outpatient visits. Table 1
shows the total number of patients, total visit, age, sex, and
number of visits per year. Overall, the number of patients and
visits is increasing year by year. Age, sex, and number of visits are
the same for each year.
3.1. Waiting time
We visualized the process of receiving the patient’s treatment in
the hospital as shown in Figure 1. The time taken before and
during each process is shown in Figure 1 as the mean, standard
deviation and median. Out of a total of 10,638 patients, 7682
patients underwent baseline blood sample and test prior to
outpatient registration and the time taken for this process was
57.66±92.93 (mean± standard deviation) minutes (median, 46).
A total of 10,368 outpatient registered patients underwent an
outpatient session. After outpatient registration, the total office
stay time taken registration to outpatient session was 92.58±
87.96 (median, 73), office waiting time was 68.84±70.75
(median, 55), and session time was 23.75±51.55minutes
(median, 8). A total of 6027 patients out of 10,638 patients
received chemotherapy after the outpatient session; the rest of the
patients received inpatient chemotherapy after admission. AfterTable 1
Baseline demographics.
2009 2010
No. of patients 2965 3474





Male 1819 (61.3) 2126 (61.2)
Female 1146 (38.7) 1348 (38.8)
Visit number
1 772 (26.0) 957 (27.5)
2–10 1697 (57.2) 2003 (57.7)
10–30 482 (16.3) 502 (14.5)
>30 14 (0.5) 12 (0.3)
Total infusion room waiting time, min 1992.8±3144.2 1617±3046.4
Mean±SD (median) (181.5) (115)
Values are presented as number (%) unless otherwise indicated.
SD= standard deviation.
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termination of the outpatient session, the patient’s infusion room
waiting time (time interval between leaving the outpatient area to
enter the infusion room) was 1657.23±3027.65minutes (medi-
an, 112) and within infusion room waiting time (time interval
between entering the infusion room to receiving chemotherapy)
was 46.66±75.94minutes (median, 26).
3.2. Analysis pre- and postenforcement of reservation
system for infusion room
We conducted an analysis of patient waiting time differences with
the introduction of reservation system for infusion room
appointments. The preinitiative (from January 2013 to February
2014) included 2002 patients with a total of 16,149 visits. The
postinitiative (fromMay 2014 to December 2017) included 5564
patients with a total of 45,740 visits. A comparative analysis
showed an improvement in overall waiting time with the new
reservation system from 2432.3±4822.9 (median, 80) to 2386.7
±5,143.4 (median, 103) minutes, although the variance in
waiting time increased. The waiting time within the infusion
room increased from 36.68±49.33 (median, 25) to 48.13±
46.32 (median, 32) minutes, while the variance decreased.
Time-series analysis of total infusion room waiting time
showed a downward-level break after introduction of the
infusion room reservation system (P= .359) (Fig. 2A). Right
after the introduction of the reservation system, the estimated
mean for waiting time of infusion room dropped abruptly by
80.113minutes per month. Interestingly, waiting time showed an
upward trend (P value for baseline trend= .019) before the
introduction of the system, but a marked downward trend after
(P value for trend change= .026). Right after the introduction of
the reservation system, the estimated mean waiting time of within
infusion room statistically significant increased abruptly by
15.949minutes per month (P  .001) (Fig. 2B). There was no
significant month-to-month change in the mean waiting time of
within infusion room pre- and postinitiative, respectively (P= .66
and P= .691). The light blue shading in Figure 2 represents the
monthly confidence interval.Year
2011 2012 2013 2014
4262 4711 4741 5135
22,263 26,433 24,797 27,825
58.50±10.72 59.23±10.81 59.37±11.03 59.10±11.08
(59) (59) (59) (59)
2642 (62.0) 2924 (62.1) 2858 (60.3) 3106 (60.5)
1620 (38.0) 1787 (37.9) 1883 (39.7) 2029 (39.5)
1194 (28.0) 1.249 (26.5) 1249 (26.3) 1383 (26.9)
2422 (56.8) 2.611 (55.4) 2754 (58.1) 2882 (56.1)
635 (14.9) 840 (17.8) 732 (15.4) 849 (16.5)
11 (0.3) 11 (0.2) 6 (0.1) 21 (0.4)
1620.3±2867 1681.5±3049.9 1749±3270.4 1449.7±2833.8
(120) (119) (116) (83)
Figure 1. Diagram of waiting time by typical patient flow process in patients with outpatient chemotherapy.
Kim et al. Medicine (2020) 99:39 Medicine4. Discussion
Office waiting is around 2hours and variability related to patients
waiting in the office and infusion room is large, which leads to
frustration between patients and care providers. By interveningFigure 2. Changes in (A) overall and (B) within infusion room
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the scheduling process of chemotherapy infusions, waiting time
from the outpatient area to actual infusion decreased. This
hospital transaction data analysis based on health information
systems and electronic health records data has allowed us towaiting time according to the use of reservation system.
Kim et al. Medicine (2020) 99:39 www.md-journal.comcapture real-world practice and assess impacts of interventions
directed to clinical operations.
Waiting time has been a long-standing issue within medicine.
Patient waiting time is one of the indicators for measuring the
quality of healthcare offered by the hospital,[8] longwait times are
a barrier to receiving medical services [9] and negatively affects
patient satisfaction of healthcare.[10–12] It has been divided into 2
categories; one has been the time from patient referral to the time
patients actually see specialist and another the actual time
patient’s wait and stay within the clinic. We have chosen to
approach the later because all the data was accessible within a
single institutional data warehouse by integrating administrative
and clinical informatics extracted from the health information
system. Improving access to outpatient treatment units has been
approached by flow analysis in various institutes in endeavors to
improve patient care.[13,14] As cancer patient care involves
various departments including outpatient clinic, radiology,
pharmacy, laboratory services, and the oncology treatment
facility, it is a complicated flow with various steps.[2,15] Woodall
et al[16] have modeled the patient flow at Duke Cancer Institute
and have shown that nurse unavailability during oncology
treatment caused a serious bottleneck in patient flow based on
simulation. Others have also utilized discrete event simulation to
analyze the patient flow and find measures to lessen patient
waiting time at cancer chemotherapy units. These simulation
studies analyze the process, collect data, build scenarios, and run
simulations.[17] While these studies build strong models, they can
be limited by various factors. Models are built on data collected
from limited numbers of patients, which may not reflect the real
world. In addition, although models are built meticulously, the
impacts of interventions are limited to simulation data.[18]
We collected data by integrating health data including
administrative and clinical informatics to reconstruct patient
flow based on event-driven patient-tracking approach.[19] Patient
flow was tracked by deducing their location through changes in
their last known status. Previously, patient flow analysis and
chemotherapy scheduling studies were based on methods that tag
patients with tracking tools or use extra personals to follow
patients to analyze patient flow.[20,21] However, because of
limited resources, evaluation was confined to limited periods and
patients that would lead to results that would be directly used in
everyday practice. Event-driven patient-tracking approach has
allowed us to connect administrative and clinical informatics to
achieve quality improvements, increase patient access and cost
controls by assessing interventional impacts with real-world data.
In addition, real-world data allowed us to identify unexpected
findings. One notable finding was that the waiting time within the
infusion room slightly increased (from 36.68±49.33 [median,
25] to 48.13±46.32 [median, 32] minutes) compared to the
waiting time in the infusion room (from 2,432.3±4,822.9
[median, 80] to 2,386.7±5,143.4 [median, 103] minutes). This
result can be confirmed in segmented regression analysis.
Through segmented regression analysis, we found a decrease
in the waiting time of infusion room after introducing the
reservation system (P= .003). This analysis showed that the
infusion room waiting time was increased continuously before
the introduction of the reservation system (P= .019), but it
decreased significantly after the introduction of the reservation
system (P= .026). On the contrary, waiting time of within
infusion room increased significantly (P< .001). After interview-
ing the workforce, we found that this was related to the fact that
prescheduling was less flexible than first come, first serve that led5
to delays during crowded periods. This was related to the fact
that resource was allocated according to the prescheduled
number of patients, which led to insufficient resource in crowded
periods despite prescheduling because of overcrowding itself.
Detrimental effects of this overcrowding effect are often reported
seen in delays of procedures within the emergency depart-
ment.[22,23] While the overcrowding associated with the
emergency room is usually related to variations in input of
patients, the overcrowding observed in this study was related to
overbooking. Some have reported that overbooking can improve
insufficient patient access by compensating no-shows; however,
more studies are required to define the optimal setting of
overbooking.[24–26]
Althoughwe have shown that impacts of quality improvement
interventions can be captured with real-world data, there
are various limitations. As the data was confined to those that
could be extracted from the warehouse, it could not capture
everyday practice completely. For example, the presence of
caregivers, number of patients with other indications besides
colorectal cancer arriving at the clinic and chemotherapy
unit, and workforce variability are just some of factors. The
quantity and quality of each visit also is very important, that is
visits that include disease response evaluation and complications
would take longer and increase variability. However, as these
factors would be random due to the large number of patients, the
significance of interventional changes can still be assessed.
Through this study we have also explored many aspects
to improve on. For example, nurses within the clinic help
patients understand many points that took place within the
office after physicians have seen the patients; however, this could
not be captured. As this study was performed on data collected
over 5 years, there can be some confounding factors over that
period. However, except for the change in chemotherapy
scheduling, there were no changes in the treatment process or
regimens.
We conclude that health information-based data warehouses
can help hospitals understand the patient flow and provide data-
driven assessments of quality improvement measures. We hope
that these practices will lessen the patients’ frustrations related to
operational inefficiencies.Author contributions
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